Market Performance - The Hong Kong pharmaceutical sector saw a slight increase, with the CSI Hong Kong Stock Connect Pharmaceutical and Health Index rising by 0.2% and the Hang Seng Stock Connect Innovative Drug Index increasing by 0.1% [1] - Conversely, the CSI Innovative Drug Industry Index and the CSI Biotech Theme Index experienced declines of 0.2% and 0.5%, respectively, while the CSI 300 Pharmaceutical and Health Index fell by 0.4% [1] Investment Trends - The Hang Seng Innovative Drug ETF (159316) has attracted continuous investment for 16 trading days, reaching a record high of 1.08 billion yuan [1] - China International Capital Corporation (CICC) expresses optimism about the long-term development trend of innovative drugs, supported by domestic engineer advantages, abundant clinical resources, and favorable policies [1]
恒生创新药ETF（159316）连续“吸金”，最新规模超10亿元，创历史新高
Mei Ri Jing Ji Xin Wen·2025-08-06 12:46